Table of Contents
ISRN Gastroenterology
Volume 2012 (2012), Article ID 394545, 6 pages
http://dx.doi.org/10.5402/2012/394545
Research Article

Lowly Expressed Ribosomal Protein S19 in the Feces of Patients with Colorectal Cancer

1Department of Anesthesiology, Sijhih Cathay General Hospital, New Taipei 22174, Taiwan
2School of Medicine, Fu Jen Catholic University, New Taipei 24257, Taiwan
3Department of Internal Medicine, Cathay General Hospital, Taipei 10630, Taiwan
4School of Medicine, Taipei Medical University, Taipei 11031, Taiwan
5Department of Medical Research, Cathay General Hospital, Taipei 10630, Taiwan
6Department of Biochemistry, National Defense Medical Center, Taipei 11490, Taiwan
7Department of Surgery, Taipei-Veterans General Hospital, Taipei 11217, Taiwan
8School of Medicine, National Yang Ming University, Taipei 11221, Taiwan
9Department of Internal Medicine, Hsinchu Cathay General Hospital, Hsinchu 30060, Taiwan

Received 16 August 2011; Accepted 4 October 2011

Academic Editors: A. Amedei and S. Grösch

Copyright © 2012 Chih-Cheng Chien et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Bardelli and V. E. Velculescu, “Mutational analysis of gene families in human cancer,” Current Opinion in Genetics and Development, vol. 15, no. 1, pp. 5–12, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Rozen, “Cancer of the gastrointestinal tract: early detection or early prevention?” European Journal of Cancer Prevention, vol. 13, no. 1, pp. 71–75, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Vogelstein, E. R. Fearon, S. R. Hamilton et al., “Genetic alterations during colorectal-tumor development,” New England Journal of Medicine, vol. 319, no. 9, pp. 525–532, 1988. View at Google Scholar · View at Scopus
  5. N. Beerenwinkel, T. Antal, D. Dingli et al., “Genetic progression and the waiting time to cancer,” PLoS Computational Biology, vol. 3, article e225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Center, A. Jemal, R. A. Smith, and E. Ward, “Worldwide variations in colorectal cancer,” CA Cancer Journal for Clinicians, vol. 59, no. 6, pp. 366–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Kimura, M. Sumiyoshi, and K. Baba, “Antitumor activities of synthetic and natural stilbenes through antiangiogenic action,” Cancer Science, vol. 99, no. 10, pp. 2083–2096, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. C. Watine and P. S. Bunting, “Mass colorectal cancer screening: methodological quality of practice guidelines is not related to their content validity,” Clinical Biochemistry, vol. 41, no. 7-8, pp. 459–466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Kikuchi-Yanoshita, M. Konishi, S. Ito et al., “Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients,” Cancer Research, vol. 52, no. 14, pp. 3965–3971, 1992. View at Google Scholar · View at Scopus
  10. D. P. Lane and S. Benchimol, “p53: oncogene or anti-oncogene?” Genes and Development, vol. 4, no. 1, pp. 1–8, 1990. View at Google Scholar · View at Scopus
  11. B. Iacopetta, “TP53 mutation in colorectal cancer,” Human Mutation, vol. 21, no. 3, pp. 271–276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Hague and C. Paraskeva, “Apoptosis and disease: a matter of cell fate,” Cell Death and Differentiation, vol. 11, no. 12, pp. 1366–1372, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. L. J. Hofseth, S. P. Hussain, and C. C. Harris, “p53: 25 years after its discovery,” Trends in Pharmacological Sciences, vol. 25, no. 4, pp. 177–181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Kobayashi, Y. Sasaki, Y. Oshima et al., “Activation of the ribosomal protein L13 gene in human gastrointestinal cancer,” International Journal of Molecular Medicine, vol. 18, no. 1, pp. 161–170, 2006. View at Google Scholar · View at Scopus
  15. H. Wang, L. N. Zhao, K. Z. Li, R. Ling, X. J. Li, and L. Wang, “Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer,” BMC Cancer, vol. 6, article no. 91, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. Anderson, J. P. H. Lauritsen, M. G. Hartman et al., “Ablation of ribosomal protein L22 selectively impairs αβ T cell development by activation of a p53-dependent checkpoint,” Immunity, vol. 26, no. 6, pp. 759–772, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Chen, Z. Zhang, M. Li et al., “Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: Binding to MDM2, stabilization of p53 protein, and activation of p53 function,” Oncogene, vol. 26, no. 35, pp. 5029–5037, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ofir-Rosenfeld, K. Boggs, D. Michael, M. B. Kastan, and M. Oren, “Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26,” Molecular Cell, vol. 32, no. 2, pp. 180–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. L. T. Tien, C. C. Chien, S. H. Yang, C. M. Lin, Y. Y. Wu, and C. J. Huang, “p53-dependent expression of ribosomal protein S27-like in colorectal cancer,” Fu-Jen Journal of Medicine, vol. 8, no. 1, pp. 11–19, 2010. View at Google Scholar
  20. C.-J. Huang, S.-H. Yang, S.-M. Huang et al., “A predicted protein, KIAA0247, is a cell cycle modulator in colorectal cancer cells under 5-FU treatment,” Journal of Translational Medicine, vol. 9, article 82, 2011. View at Publisher · View at Google Scholar
  21. S. Kanaoka, K. I. Yoshida, N. Miura, H. Sugimura, and M. Kajimura, “Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening,” Gastroenterology, vol. 127, no. 2, pp. 422–427, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. N. Yang, S. H. Yang, C. C. Chang, C. C. Chien, S. Pan, and C. J. Huang, “Upregulation of fecal cytokeratin 19 is associated with prognosis in older colorectal cancer patients,” Genetic Testing and Molecular Biomarkers, vol. 14, no. 5, pp. 703–708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. C. J. Huang, C. C. Chien, S. H. Yang et al., “Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer,” Journal of Cellular and Molecular Medicine, vol. 12, no. 5B, pp. 1936–1943, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Danilova, K. M. Sakamoto, and S. Lin, “Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family,” Blood, vol. 112, no. 13, pp. 5228–5237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. C. Chang, S. H. Yang, C. C. Chien et al., “Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy,” BMC Cancer, vol. 9, article no. 376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. C. Chien, C. C. Chang, S. H. Yang, S. H. Chen, and C. J. Huang, “A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer,” Oncology reports., vol. 15, no. 4, pp. 919–926, 2006. View at Google Scholar · View at Scopus
  27. V. Ramakrishnan and P. B. Moore, “Atomic structures at last: the ribosome in 2000,” Current Opinion in Structural Biology, vol. 11, no. 2, pp. 144–154, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. I. G. Wool, “The structure and function of eukaryotic ribosomes,” Annual Review of Biochemistry, vol. 48, pp. 719–754, 1979. View at Google Scholar · View at Scopus
  29. A. W. MacInnes, A. Amsterdam, C. A. Whittaker, N. Hopkins, and J. A. Lees, “Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10408–10413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Takagi, M. J. Absalon, K. G. McLure, and M. B. Kastan, “Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin,” Cell, vol. 123, no. 1, pp. 49–63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Panić, S. Tamarut, M. Sticker-Jantscheff et al., “Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation,” Molecular and Cellular Biology, vol. 26, no. 23, pp. 8880–8891, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Li, J. Tan, L. Zhuang et al., “Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress,” Cancer Research, vol. 67, no. 23, pp. 11317–11326, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Hegde, S. Yadavilli, and W. A. Deutsch, “Knockdown of ribosomal protein S3 protects human cells from genotoxic stress,” DNA Repair, vol. 6, no. 1, pp. 94–99, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. D. W. Shen, X. J. Liang, T. Suzuki, and M. M. Gottesman, “Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and the 10-kDa heat shock protein that confer cisplatin resistance,” Molecular Pharmacology, vol. 69, no. 4, pp. 1383–1388, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Shi, H. Zhai, X. Wang et al., “Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis,” Experimental Cell Research, vol. 296, no. 2, pp. 337–346, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Bee, Y. Ke, S. Forootan et al., “Ribosomal protein L19 is a prognostic marker for human prostate cancer,” Clinical Cancer Research, vol. 12, no. 7, pp. 2061–2065, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. D. C. Chung, “Stool DNA testing and colon cancer prevention: another step forward,” Annals of Internal Medicine, vol. 149, no. 7, pp. 509–510, 2008. View at Google Scholar · View at Scopus
  38. S. Yajima, M. Ishii, H. Matsushita et al., “Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer,” International Journal of Oncology, vol. 31, no. 5, pp. 1029–1037, 2007. View at Google Scholar · View at Scopus
  39. M. J. Clemens, “Targets and mechanisms for the regulation of translation in malignant transformation,” Oncogene, vol. 23, no. 18, pp. 3180–3188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Badhai, J. Schuster, O. Gidlöf, and N. Dahl, “5′UTR variants of ribosomal protein S19 transcript determine translational efficiency: Implications for Diamond-Blackfan anemia and tissue variability,” PLoS One, vol. 6, no. 3, Article ID e17672, 2011. View at Publisher · View at Google Scholar
  41. J. Flygare and S. Karlsson, “Diamond-Blackfan anemia: erythropoiesis lost in translation,” Blood, vol. 109, no. 8, pp. 3152–3154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Sturm, C. H. Köhne, G. Wolff et al., “Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases,” Journal of Clinical Oncology, vol. 17, no. 5, pp. 1364–1374, 1999. View at Google Scholar · View at Scopus
  43. Y. Koga, M. Yasunaga, S. Katayose et al., “Improved recovery of exfoliated colonocytes from feces using newly developed immunomagnetic beads,” Gastroenterology Research Practice, vol. 2008, Article ID 605273, 7 pages, 2008. View at Publisher · View at Google Scholar